ANDA 75580, held by Apotex. Doxazosin Mesylate.
As of Nov 16, 2026, ANDA 75580 (Doxazosin Mesylate), held by Apotex, was first approved by FDA on Oct 18, 2000, with 12 approved supplements and 0 published complete response letters.
Doxazosin tablets are an alpha 1 adrenergic antagonist indicated for:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 18, 2000 | Original application | Approved |
| Doxazosin MesylateEQ 1MG BASE · tablet;oral | Doxazosin Mesylate | Rx |
| Doxazosin MesylateEQ 2MG BASE · tablet;oral | Doxazosin Mesylate | Rx |
| Doxazosin MesylateEQ 4MG BASE · tablet;oral | Doxazosin Mesylate | Rx |
| Doxazosin MesylateEQ 8MG BASE · tablet;oral | Doxazosin Mesylate | Rx |
| Sep 27, 2024 | Supplement 25Labeling · Standard review | Approved | None posted |
| Sep 27, 2024 | Supplement 24Labeling · Standard review | Approved | None posted |
| Feb 21, 2017 | Supplement 21Labeling · Standard review | Approved | None posted |
| Sep 21, 2014 | Supplement 20Labeling · Standard review | Approved | None posted |
| Sep 21, 2014 | Supplement 19Labeling | Approved | None posted |
| Jun 7, 2006 | Supplement 14Labeling | Approved | None posted |
| Jan 31, 2006 | Supplement 13Labeling | Approved | None posted |
| Mar 18, 2005 | Supplement 11Labeling | Approved | None posted |
| Aug 28, 2002 | Supplement 4Labeling | Approved | None posted |
| Jan 24, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Sep 21, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Jan 19, 2001 | Supplement 1Labeling | Approved | None posted |
| Oct 18, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters